ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 270 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $15,000 | -40.0% | 583 | +22.7% | 0.01% | -56.2% |
| Q4 2020 | $25,000 | +25.0% | 475 | 0.0% | 0.02% | +6.7% |
| Q3 2020 | $20,000 | -13.0% | 475 | 0.0% | 0.02% | -21.1% |
| Q2 2020 | $23,000 | +15.0% | 475 | 0.0% | 0.02% | +26.7% |
| Q1 2020 | $20,000 | 0.0% | 475 | 0.0% | 0.02% | +87.5% |
| Q4 2019 | $20,000 | +53.8% | 475 | 0.0% | 0.01% | +33.3% |
| Q2 2019 | $13,000 | – | 475 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |